Merck KGaA/ DE0006599905 /
2024-04-19 5:35:30 PM | Chg. -0.30 | Volume | Bid5:35:30 PM | Ask5:35:30 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
146.10EUR | -0.20% | 91,324 Turnover: 6.27 mill. |
-Bid Size: - | -Ask Size: - | 18.84 bill.EUR | 1.51% | 22.47 |
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA